4basebio UK Societas 4BB

LON: 4BB | ISIN: GB00BLD8ZL39   16/04/2025
1.125,00 GBX (-0,44%)
(-0,44%)   16/04/2025

4 april 2025 · 4basebio Plc - Director Dealing · Persbericht

2 april 2025 · 4basebio Plc - 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility · Persbericht

25 maart 2025 · 4basebio Plc - Holding(s) in Company · Persbericht

14 maart 2025 · 4basebio Plc - RBC Capital Markets initiates research coverage · Persbericht

7 maart 2025 · 4basebio Plc - Employee Long Term Incentive Plan and Issue of Equity · Persbericht

3 maart 2025 · 4basebio Plc - Director's Dealing · Persbericht

9 september 2024 · 4basebio Plc - Update re Equity Issuance, Secondary Sale and the board · Persbericht

8 augustus 2024 · 4basebio Plc - Strategic Advisory Board & Appointment of Director · Persbericht

29 juli 2024 · 4basebio Plc - £40.0m Equity Issuance and £29.4m Secondary Sale · Persbericht

18 juli 2024 · 4basebio Plc - Employee Long Term Incentive Plan and Issue of Equity · Persbericht

28 juni 2024 · 4basebio Plc - Result of AGM · Persbericht

11 juni 2024 · 4basebio Plc - Holding(s) in Company · Persbericht

11 juni 2024 · 4basebio Plc - Holding(s) in Company · Persbericht

5 juni 2024 · 4basebio Plc - Final Results and Notice of AGM · Persbericht

30 mei 2024 · 4basebio Plc - Holding(s) in Company · Persbericht

10 april 2024 · 4basebio Plc - 4basebio announces the supply of its opDNA™ DNA products into Tier 1 Pharma client's vaccine program · Persbericht

21 maart 2024 · 4basebio Plc - 4basebio client's Phase I clinical trials for opDNA™ based mRNA vaccine · Persbericht

1 maart 2024 · 4basebio Plc - 4basebio awarded tender to deliver research and GMP-grade synthetic DNA in CPI's tender process for supplying its RNA Centre of Excellence · Persbericht

6 februari 2024 · 4basebio Plc - Holding(s) in Company · Persbericht

6 februari 2024 · 4basebio Plc - Exercise of Options · Persbericht

Mijn selecties